Tag: MI
-
2018 Emerging Drug Litigations: Viberzi and Actemra
Additional information concerning the potentially harmful side effects of Viberzi and Actemra was released over the course of 2017, and we will continue to monitor the situation in 2018.
-
Farxiga / Jardiance / Invokana Safety As Regards Diabetic Ketoacidosis Now Being Studied By Health Canada In Addition To Current FDA Investigation
Institute For Safe Medication Practices Signal For Invokana Kidney Failure Risks Seems To Apply To Farxiga, Jardiance, And Other SGLT2 Diabetes Drugs Also (Posted by Tom Lamb at DrugInjuryWatch.com) ________________________________________________________________________________ UPDATE: “Health Canada…
-
Summer 2014 Update: Testosterone “Low-T” Drugs: New FDA Safety Warnings; Recent Medical Journal Article About Heart Risks Of Injectable TRT Products
All Testosterone Therapy Drugs Need To Warn About Blood Clots Side Effects Like DVT And PE; Older Depo-Testosterone Product May Be Safer Than New Gels Such As AndroGel And Testim (Posted by Tom Lamb…
-
New 2012 Medical Study Shows NuvaRing Doubles The Risk Of Stroke And Heart Attack, And The Degree Of Risk Increases With Age
NuvaRing Contraceptive Vaginal Ring Associated With Blood Clots In Arteries That Might Cause Thrombotic Strokes And Myocardial Infarctions (MI) (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: "October 2013 NuvaRing Label Change: Warnings And Precautions…
-
Pradaxa Noted For Possible Heart Attack Risk In Addition To Serious Gastrointestinal Bleeding And Other Hemorrhages
Recent Medical Article And Poster Presentation Both Point To A Trend Toward Increased Rate Or Risk Of Myocardial Infarction (MI) (Posted by Tom Lamb at DrugInjuryWatch.com) A recent "position paper" by a group of…
-
Focus on Pradaxa Pradaxa® is the name under which Boehringer Ingelheim Pharmaceuticals, Inc. markets a prescription anticoagulant medication generically called dabigatran. _______________________________________________________________________________ Free Pradaxa Case Evaluation The information you provide to us for…
-
YAZ / Yasmin / Ocella: FDA Study Suggests An Increased Risk Of Blood Clots That Can Cause Side Effects Like Pulmonary Embolism
Early Results Suggest An Approximately 1.5-fold Increase In The Risk For Birth Control Pills With Drospirenone (DRSP) (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: YAZ / Yasmin / Ocella Update: October 2011 FDA…
-
November 2009 Medical Journal Article Describes Large Ongoing Study About Safety Of YAZ
INAS-OC Study: Intended To Evaluate Risk Of Developing Cardiovascular Side Effects For Women Who Use YAZ (DRSP/EE 24d) (Posted by Tom Lamb at DrugInjuryWatch.com) In May 2009 we first wrote about the International Active…